Enhanced therapeutic effect of methotrexate in experimental rat leukemia after inactivation of cobalamin (vitamin B12) by nitrous oxide.
Exposure to nitrous oxide interferes selectively with the coenzyme function of vitamin B12 and causes inactivation of methionine synthetase, with subsequent impairment of folate metabolism and reduction of cellular proliferation. In a rat leukemia model (BNML) we investigated the combined administration of nitrous oxide, inactivating vitamin B12, and methotrexate (MTX), a folate antagonist inhibiting the enzyme dihydrofolate reductase. Through different mechanisms, both agents decrease the availability of tetrahydrofolate, and subsequently of other reduced folates, with increased impairment of folate-dependent synthesis of thymidylate. Effects on leukemic growth and on hematological values in rats demonstrated enhancement of the therapeutic effect of MTX by exposure to nitrous oxide. With several treatment schedules, the results of combined treatment were seen to be better than additive when compared with the effects of single agents. In particular, pretreatment of leukemic rats with nitrous oxide for 3 days before administration of MTX appeared effective. With higher doses of MTX, concomitant exposure to nitrous oxide even resulted in toxic effects. These findings were in accordance with the results of some metabolic studies performed in leukemic rats.(ABSTRACT TRUNCATED AT 250 WORDS)
D000818:Animals; D001772:Blood Cell Count; D003857:Deoxyuridine / Q000378:metabolism; D004334:Drug Administration Schedule; D004357:Drug Synergism; D005492:Folic Acid / Q000378:metabolism; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D009609:Nitrous Oxide / Q000008:administration & dosage*; D051381:Rats; D013942:Thymine Nucleotides / Q000378:metabolism; D014805:Vitamin B 12 / Q000037:antagonists & inhibitors*
D013942:Thymine Nucleotides; D005492:Folic Acid; D009609:Nitrous Oxide; D014805:Vitamin B 12; D003857:Deoxyuridine; D008727:Methotrexate